oxonic acid has been researched along with Pyrexia in 4 studies
Oxonic Acid: Antagonist of urate oxidase.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Patients were eligible for the study if they had histologically documented gastric adenocarcinoma previously treated with paclitaxel and cisplatin, age > or = 18 years, Eastern Clinical Oncology Group performance status < or =2, adequate organ function, and no evidence of gastrointestinal obstruction or passage disturbance." | 5.14 | Phase II study of S-1 monotherapy in paclitaxel- and cisplatin-refractory gastric cancer. ( Bae, WK; Cho, SH; Chung, IJ; Hwang, JE; Lee, SJ; Shim, HJ; Yoon, JY, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 2 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Saito, Y | 1 |
| Hara, H | 1 |
| Tsujie, M | 1 |
| Miyamoto, A | 1 |
| Asaoka, T | 1 |
| Yamamoto, K | 1 |
| Ikenaga, M | 1 |
| Miyazaki, M | 1 |
| Ikeda, M | 1 |
| Hirao, M | 1 |
| Fujitani, K | 1 |
| Sekimoto, M | 1 |
| Nakamori, S | 1 |
| Lee, SJ | 1 |
| Cho, SH | 1 |
| Yoon, JY | 1 |
| Hwang, JE | 1 |
| Bae, WK | 1 |
| Shim, HJ | 1 |
| Chung, IJ | 1 |
| Ichinose, Y | 1 |
| Seto, T | 1 |
| Sasaki, T | 1 |
| Yamanaka, T | 1 |
| Okamoto, I | 1 |
| Takeda, K | 1 |
| Tanaka, M | 1 |
| Katakami, N | 1 |
| Sawa, T | 1 |
| Kudoh, S | 1 |
| Saka, H | 1 |
| Nishimura, Y | 1 |
| Nakagawa, K | 1 |
| Fukuoka, M | 1 |
| Lee, JL | 1 |
| Kang, HJ | 1 |
| Kang, YK | 1 |
| Ryu, MH | 1 |
| Chang, HM | 1 |
| Kim, TW | 1 |
| Sohn, HJ | 1 |
| Kim, H | 1 |
| Lee, JS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Phase III Trial of S-1 and Cisplatin (3 Weekly) Versus S-1 and Oxaliplatin Combination Chemotherapy for First Line Treatment of Advanced Gastric Cancer[NCT01671449] | Phase 3 | 338 participants (Actual) | Interventional | 2012-12-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 trials available for oxonic acid and Pyrexia
| Article | Year |
|---|---|
Phase II study of S-1 monotherapy in paclitaxel- and cisplatin-refractory gastric cancer.
Topics: Adenocarcinoma; Adult; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic | 2009 |
S-1 plus cisplatin with concurrent radiotherapy for locally advanced non-small cell lung cancer: a multi-institutional phase II trial (West Japan Thoracic Oncology Group 3706).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Chemora | 2011 |
Phase I/II study of 3-week combination of S-1 and cisplatin chemotherapy for metastatic or recurrent gastric cancer.
Topics: Adult; Aged; Anemia; Anorexia; Antineoplastic Combined Chemotherapy Protocols; Cisplatin; Diarrhea; | 2008 |
1 other study available for oxonic acid and Pyrexia
| Article | Year |
|---|---|
[A Case of Subacute Thyroiditis during Chemotherapy after Distal Pancreatectomy].
Topics: Aged; Anti-Inflammatory Agents; Antimetabolites; Drug Combinations; Fatal Outcome; Female; Fever; Hu | 2016 |